Cancellations and suspensions
This database records details of medicines and medical devices that have been cancelled or suspended, and no longer appear in the ARTG.
Following a review by the TGA, complementary medicines can be cancelled from the Australian Register of Therapeutic Goods. These cancellations are made by the Secretary under section 30 of the Therapeutic Goods Act 1989.
Where other actions are taken in relation to safety, a link to the TGA's safety alert will be included in the database under 'Further information'.
The reasons for a cancellation are stated in the database below under 'Grounds for cancellation'.
The heading 'Decision status' provides updated information about cancellation decisions, for example information about any decision to revoke a cancellation decision. It will not appear in every entry.
To find out whether a product is currently authorised for supply in Australia, check the ARTG.
Last updated
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medical device cancellation (855)
- Medicine suspension (506)
- Complementary medicine cancellation (206)
- Medical device suspension (89)
- Medicine cancellation (59)
- Revocation of a TGA issued Conformity Assessment Certificate (55)
- Voluntary revocation at the request of the manufacturer (39)
- Medical device cancellation - certain devices within an entry (23)
- Registered medicine cancellation (14)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
- Medical device cancellation (7)
- Listed medicine cancellation (5)
- Complementary medicine cancellation (4)
- Listed medicine cancellation (4)
- Revocation of a TGA issued Conformity Assessment Certificate. (3)
- Revocation of medical device suspension (3)
- Revoked medicine suspension (2)
- AFT Pharmaceuticals Pty Ltd (1)
- Alphapharm Pty Ltd (1)
- Complementary Medicine Cancellation (1)
- Medical device cancellation (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
- Voluntary revocation at the request of the manufacturer. (1)
Find out more about Cancellations and Suspensions.
Search
1921 result(s) found, displaying 1551 to 1575
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 16/12/2019
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of inclusion in that the sponsor failed to provide information to the Secretary as required in response to section 41JA, effective 27/11/2019
-
Cancellation or suspensionRegulatory action due to As part of the conditions of inclusion the sponsor did not provide annual report information, the sponsor failed to comply with an automatic condition of inclusion under s41FN(5A) of the Act., effective 18/11/2019
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of inclusion in that the sponsor failed to provide information to the Secretary as required in response to section 41JA., effective 12/11/2019
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of inclusion in that the sponsor failed to provide information to the Secretary as required in response to section 41JA, effective 07/11/2019
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of inclusion in that the sponsor failed to provide information to the Secretary as required in response to section 41JA., effective 05/11/2019
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of inclusion in that the sponsor failed to provide information to the Secretary as required in response to section 41JA., effective 04/11/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 41GA(1)(b); it is likely that there are grounds for cancelling this kind of device from the ARTG under subsection 41GN(1)(b)., effective 25/10/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 41GA(1)(b); it is likely that there are grounds for cancelling this kind of device from the ARTG under subsection 41GN(1)(b)., effective 25/10/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 41GA(1)(b); it is likely that there are grounds for cancelling this kind of device from the ARTG under subsection 41GN(1)(b)., effective 25/10/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 41GA(1)(b); it is likely that there are grounds for cancelling this kind of device from the ARTG under subsection 41GN(1)(b)., effective 25/10/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 41GA(1)(b); it is likely that there are grounds for cancelling this kind of device from the ARTG under subsection 41GN(1)(b)., effective 25/10/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 41GA(1)(b); it is likely that there are grounds for cancelling this kind of device from the ARTG under subsection 41GN(1)(b)., effective 25/10/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 41GA(1)(b); it is likely that there are grounds for cancelling this kind of device from the ARTG under subsection 41GN(1)(b)., effective 25/10/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 41GA(1)(b); it is likely that there are grounds for cancelling this kind of device from the ARTG under subsection 41GN(1)(b)., effective 25/10/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 41GA(1)(b); it is likely that there are grounds for cancelling this kind of device from the ARTG under subsection 41GN(1)(b)., effective 18/10/2019
-
Cancellation or suspensionRegulatory action due to Under subsection 41GA(1)(b); it is likely that there are grounds for cancelling this kind of device from the ARTG under subsection 41GN(1)(b)., effective 11/09/2019
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the quality, safety or efficacy of the goods was unacceptable. It appeared to the Secretary that a certification made by the sponsor under paragraph 26A(2)(b) of the Act was incorrect. The Secretary was satisfied that a statement made in, or in connection with, the application for listing of the goods was false or misleading in a material particular. The goods did not conform to a standard applicable to the goods., effective 02/09/2019
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with the notice under section 41JA requiring to provide information and to demonstrate that all matters certified under section 41FD of the Therapeutic Goods Act 1989 were correct, in a material particular., effective 20/08/2019
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with the notice under section 41JA requiring to provide information and to demonstrate that all matters certified under section 41FD of the Therapeutic Goods Act 1989 were correct, in a material particular., effective 20/08/2019
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with the notice under section 41JA requiring to provide information and to demonstrate that all matters certified under section 41FD of the Therapeutic Goods Act 1989 were correct, in a material particular., effective 20/08/2019
Last updated